709 related articles for article (PubMed ID: 23034130)
1. Cancer classification using the Immunoscore: a worldwide task force.
Galon J; Pagès F; Marincola FM; Angell HK; Thurin M; Lugli A; Zlobec I; Berger A; Bifulco C; Botti G; Tatangelo F; Britten CM; Kreiter S; Chouchane L; Delrio P; Arndt H; Asslaber M; Maio M; Masucci GV; Mihm M; Vidal-Vanaclocha F; Allison JP; Gnjatic S; Hakansson L; Huber C; Singh-Jasuja H; Ottensmeier C; Zwierzina H; Laghi L; Grizzi F; Ohashi PS; Shaw PA; Clarke BA; Wouters BG; Kawakami Y; Hazama S; Okuno K; Wang E; O'Donnell-Tormey J; Lagorce C; Pawelec G; Nishimura MI; Hawkins R; Lapointe R; Lundqvist A; Khleif SN; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Palmqvist R; Nagtegaal ID; Wang Y; D'Arrigo C; Kopetz S; Sinicrope FA; Trinchieri G; Gajewski TF; Ascierto PA; Fox BA
J Transl Med; 2012 Oct; 10():205. PubMed ID: 23034130
[TBL] [Abstract][Full Text] [Related]
2. The immune score as a new possible approach for the classification of cancer.
Galon J; Pagès F; Marincola FM; Thurin M; Trinchieri G; Fox BA; Gajewski TF; Ascierto PA
J Transl Med; 2012 Jan; 10():1. PubMed ID: 22214470
[TBL] [Abstract][Full Text] [Related]
3. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
Galon J; Mlecnik B; Bindea G; Angell HK; Berger A; Lagorce C; Lugli A; Zlobec I; Hartmann A; Bifulco C; Nagtegaal ID; Palmqvist R; Masucci GV; Botti G; Tatangelo F; Delrio P; Maio M; Laghi L; Grizzi F; Asslaber M; D'Arrigo C; Vidal-Vanaclocha F; Zavadova E; Chouchane L; Ohashi PS; Hafezi-Bakhtiari S; Wouters BG; Roehrl M; Nguyen L; Kawakami Y; Hazama S; Okuno K; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Wang Y; Kopetz S; Sinicrope FA; Scripcariu V; Ascierto PA; Marincola FM; Fox BA; Pagès F
J Pathol; 2014 Jan; 232(2):199-209. PubMed ID: 24122236
[TBL] [Abstract][Full Text] [Related]
4. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
[TBL] [Abstract][Full Text] [Related]
5. Immunoscore and its introduction in clinical practice.
Galon J; Lanzi A
Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
[TBL] [Abstract][Full Text] [Related]
6. [Intratumoral immune microenvironment and survival: the immunoscore].
Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
[TBL] [Abstract][Full Text] [Related]
7. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
Bruni D; Angell HK; Galon J
Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
[TBL] [Abstract][Full Text] [Related]
8. [Immunoscore and Its Predictive Value for Colorectal Cancer].
Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
[TBL] [Abstract][Full Text] [Related]
9. World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016.
Galon J; Lugli A; Bifulco C; Pages F; Masucci G; Marincola FM; Ascierto PA
J Transl Med; 2017 Oct; 15(1):212. PubMed ID: 29058595
[TBL] [Abstract][Full Text] [Related]
10. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.
Ros-Martínez S; Navas-Carrillo D; Alonso-Romero JL; Orenes-Piñero E
Crit Rev Clin Lab Sci; 2020 Nov; 57(7):432-443. PubMed ID: 32175789
[TBL] [Abstract][Full Text] [Related]
11. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
[TBL] [Abstract][Full Text] [Related]
12. Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.
Petrizzo A; Buonaguro L
J Immunother Cancer; 2016; 4():71. PubMed ID: 27879973
[TBL] [Abstract][Full Text] [Related]
13. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
Donnem T; Kilvaer TK; Andersen S; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Brustugun OT; Helland A; Lund-Iversen M; Solberg S; Gronberg BH; Wahl SG; Helgeland L; Fløtten O; Pohl M; Al-Shibli K; Sandanger TM; Pezzella F; Busund LT; Bremnes RM
Ann Oncol; 2016 Feb; 27(2):225-32. PubMed ID: 26578726
[TBL] [Abstract][Full Text] [Related]
14. The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.
Lanzi A; Sinicrope FA; Benson AB; Galon J
Oncoimmunology; 2020 Jul; 9(1):1796003. PubMed ID: 32934890
[TBL] [Abstract][Full Text] [Related]
15. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
Pagès F; Taieb J; Laurent-Puig P; Galon J
Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
[TBL] [Abstract][Full Text] [Related]
16. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract][Full Text] [Related]
17. Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients.
Baldin P; Van den Eynde M; Mlecnik B; Galon J
Oncoimmunology; 2020 Oct; 9(1):1826133. PubMed ID: 33110705
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.
Bindea G; Mlecnik B; Fridman WH; Galon J
Semin Immunopathol; 2011 Jul; 33(4):335-40. PubMed ID: 21461991
[TBL] [Abstract][Full Text] [Related]
19. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
20. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
